Your browser doesn't support javascript.
loading
Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT.
Ben Hassine, Khalil; Seydoux, Claire; Khier, Sonia; Daali, Youssef; Medinger, Michael; Halter, Joerg; Heim, Dominik; Chalandon, Yves; Schanz, Urs; Nair, Gayathri; Cantoni, Nathan; Passweg, Jakob R; Satyanarayana Uppugunduri, Chakradhara Rao; Ansari, Marc.
Afiliación
  • Ben Hassine K; Department of Pediatrics, Gynecology and Obstetrics, Cansearch Research Platform for Pediatric Oncology and Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Seydoux C; Division of Hematology, University Hospital of Basel, Basel, Switzerland.
  • Khier S; Pharmacokinetic and Modeling Department, School of Pharmacy, Montpellier University, Montpellier, France; Probabilities and Statistics Department, Institut Montpelliérain Alexander Grothendieck (IMAG), CNRS, UMR 5149, Inria, Montpellier University, Montpellier, France.
  • Daali Y; Division of Clinical Pharmacology and Toxicology, University Hospital of Geneva, Geneva, Switzerland; Faculty of Medicine & Sciences, University of Geneva, Geneva, Switzerland.
  • Medinger M; Division of Hematology, University Hospital of Basel, Basel, Switzerland and University Basel, Basel, Switzerland.
  • Halter J; Division of Hematology, University Hospital of Basel, Basel, Switzerland and University Basel, Basel, Switzerland.
  • Heim D; Division of Hematology, University Hospital of Basel, Basel, Switzerland and University Basel, Basel, Switzerland.
  • Chalandon Y; Division of Hematology, Bone Marrow Transplant Unit, University Hospital of Geneva and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Schanz U; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
  • Nair G; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
  • Cantoni N; Division of Oncology, Hematology and Transfusion Medicine, Kantonsspital Aarau, Aarau, Switzerland.
  • Passweg JR; Division of Hematology, University Hospital of Basel, Basel, Switzerland and University Basel, Basel, Switzerland.
  • Satyanarayana Uppugunduri CR; Department of Pediatrics, Gynecology and Obstetrics, Cansearch Research Platform for Pediatric Oncology and Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Ansari M; Department of Pediatrics, Gynecology and Obstetrics, Cansearch Research Platform for Pediatric Oncology and Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Division of Pediatric Oncology and Hematology, Department of Women, Child and Adolescent, University Geneva Hospital
Transplant Cell Ther ; 30(3): 332.e1-332.e15, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38081414
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Busulfano / Trasplante de Células Madre Hematopoyéticas Límite: Adult / Child / Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Busulfano / Trasplante de Células Madre Hematopoyéticas Límite: Adult / Child / Humans Idioma: En Año: 2024 Tipo del documento: Article